Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Gross Margin (2021 - 2025)

Historic Gross Margin for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to 58.33%.

  • HeartSciences' Gross Margin changed N/A to 58.33% in Q4 2025 from the same period last year, while for Oct 2025 it was 3.56%, marking a year-over-year change of. This contributed to the annual value of 56.78% for FY2025, which is 105200.0% down from last year.
  • As of Q4 2025, HeartSciences' Gross Margin stood at 58.33%.
  • HeartSciences' Gross Margin's 5-year high stood at 69.15% during Q2 2022, with a 5-year trough of 23.09% in Q3 2021.
  • Its 5-year average for Gross Margin is 56.31%, with a median of 61.03% in 2023.
  • Per our database at Business Quant, HeartSciences' Gross Margin soared by 132900bps in 2022 and then crashed by -78100bps in 2023.
  • Over the past 5 years, HeartSciences' Gross Margin (Quarter) stood at 23.09% in 2021, then skyrocketed by 58bps to 36.38% in 2022, then surged by 68bps to 61.03% in 2023, then grew by 13bps to 68.97% in 2024, then decreased by -15bps to 58.33% in 2025.
  • Its Gross Margin stands at 58.33% for Q4 2025, versus 60.0% for Q3 2025 and 68.97% for Q1 2024.